BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 12738417)

  • 21. Indoleamine 2,3-dioxygenase in transplantation.
    Mulley WR; Nikolic-Paterson DJ
    Nephrology (Carlton); 2008 Jun; 13(3):204-11. PubMed ID: 18221253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.
    Katz JB; Muller AJ; Prendergast GC
    Immunol Rev; 2008 Apr; 222():206-21. PubMed ID: 18364004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of indoleamine 2, 3-dioxygenase inhibiting cardiac allograft rejection in mice.
    Li C; Sun Z; Yuan F; Zhao Z; Zhang J; Zhang B; Li H; Liu T; Dai X
    J Cell Mol Med; 2020 Mar; 24(6):3438-3448. PubMed ID: 32027774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Host indoleamine 2,3-dioxygenase: contribution to systemic acquired tumor tolerance.
    Johnson TS; Munn DH
    Immunol Invest; 2012; 41(6-7):765-97. PubMed ID: 23017145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?
    Mellor AL; Munn DH
    Immunol Today; 1999 Oct; 20(10):469-73. PubMed ID: 10500295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IDO-expressing regulatory dendritic cells in cancer and chronic infection.
    Popov A; Schultze JL
    J Mol Med (Berl); 2008 Feb; 86(2):145-60. PubMed ID: 17876564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.
    Munn DH; Sharma MD; Lee JR; Jhaver KG; Johnson TS; Keskin DB; Marshall B; Chandler P; Antonia SJ; Burgess R; Slingluff CL; Mellor AL
    Science; 2002 Sep; 297(5588):1867-70. PubMed ID: 12228717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of tryptophan metabolism in cancers and therapeutic implications.
    Liu XH; Zhai XY
    Biochimie; 2021 Mar; 182():131-139. PubMed ID: 33460767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of regulatory T Cells by dendritic cells through indoleamine 2,3-dioxygenase: a potent mechanism of acquired peripheral tolerance.
    Trabanelli S; Ocadlikova D; Evangelisti C; Parisi S; Curti A
    Curr Med Chem; 2011; 18(15):2234-9. PubMed ID: 21517756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tryptophan catabolism and T cell responses.
    Mellor AL; Munn D; Chandler P; Keskin D; Johnson T; Marshall B; Jhaver K; Baban B
    Adv Exp Med Biol; 2003; 527():27-35. PubMed ID: 15206713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Much IDO about pregnancy.
    Bonney EA; Matzinger P
    Nat Med; 1998 Oct; 4(10):1128-9. PubMed ID: 9771744
    [No Abstract]   [Full Text] [Related]  

  • 32. Indoleamine 2,3-dioxygenase: from catalyst to signaling function.
    Fallarino F; Grohmann U; Puccetti P
    Eur J Immunol; 2012 Aug; 42(8):1932-7. PubMed ID: 22865044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tryptophan catabolism prevents maternal T cells from activating lethal anti-fetal immune responses.
    Mellor AL; Munn DH
    J Reprod Immunol; 2001; 52(1-2):5-13. PubMed ID: 11600174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuronal localization of indoleamine 2,3-dioxygenase in mice.
    Roy EJ; Takikawa O; Kranz DM; Brown AR; Thomas DL
    Neurosci Lett; 2005 Oct; 387(2):95-9. PubMed ID: 16076525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity.
    Liu X; Shin N; Koblish HK; Yang G; Wang Q; Wang K; Leffet L; Hansbury MJ; Thomas B; Rupar M; Waeltz P; Bowman KJ; Polam P; Sparks RB; Yue EW; Li Y; Wynn R; Fridman JS; Burn TC; Combs AP; Newton RC; Scherle PA
    Blood; 2010 Apr; 115(17):3520-30. PubMed ID: 20197554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis.
    Xiao BG; Liu X; Link H
    Steroids; 2004 Sep; 69(10):653-9. PubMed ID: 15465110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.
    Muller AJ; Sharma MD; Chandler PR; Duhadaway JB; Everhart ME; Johnson BA; Kahler DJ; Pihkala J; Soler AP; Munn DH; Prendergast GC; Mellor AL
    Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17073-8. PubMed ID: 18952840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The end of the road for the tryptophan depletion concept in pregnancy and infection.
    Badawy AA; Namboodiri AM; Moffett JR
    Clin Sci (Lond); 2016 Aug; 130(15):1327-33. PubMed ID: 27358028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human myeloid dendritic cells are refractory to tryptophan metabolites.
    von Bubnoff D; Wilms H; Scheler M; Brenk M; Koch S; Bieber T
    Hum Immunol; 2011 Oct; 72(10):791-7. PubMed ID: 21699942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecules in focus: indoleamine 2,3-dioxygenase.
    King NJ; Thomas SR
    Int J Biochem Cell Biol; 2007; 39(12):2167-72. PubMed ID: 17320464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.